EPA:SAN - Sanofi Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sanofi SA Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add €89.49 -2.08 (-2.27 %) (As of 02/27/2020 03:53 AM ET) Add Compare Today's Range€89.10Now: €89.49▼€90.3150-Day Range€86.70MA: €91.23▼€94.0052-Week Range€63.09Now: €89.49▼€92.97Volume426,318 shsAverage Volume3.05 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis. The company also provides Jevtana, a taxane derivative for prostate cancer; Taxotere, a taxoid for cancers; Eloxatin, an agent for colorectal cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, a hematopoietic stem cell mobilizer; and Zaltrap, a protein for metastatic colorectal cancer. Read More… Industry, Sector and Symbol Stock Exchange EPA Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolEPA:SAN Previous Symbol CUSIPN/A CIKN/A Webhttp://en.sanofi.com/ Phone+33-1-53774000Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Receive SAN News and Ratings via Email Sign-up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Sanofi (EPA:SAN) Frequently Asked Questions What is Sanofi's stock symbol? Sanofi trades on the EPA under the ticker symbol "SAN." What price target have analysts set for SAN? 13 brokers have issued 1-year price targets for Sanofi's shares. Their forecasts range from €85.00 to €110.00. On average, they anticipate Sanofi's share price to reach €99.46 in the next twelve months. This suggests a possible upside of 9.4% from the stock's current price. View Analyst Price Targets for Sanofi. What is the consensus analysts' recommendation for Sanofi? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 1 sell rating, 2 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sanofi. Has Sanofi been receiving favorable news coverage? Headlines about SAN stock have been trending extremely negative on Thursday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sanofi earned a daily sentiment score of -4.9 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Sanofi. Who are some of Sanofi's key competitors? Some companies that are related to Sanofi include Bayer (BAYN), HedgePath Pharmaceuticals (MAYNF), OTSUKA HOLDINGS/ADR (OTSKY), Roche (SNYNF), Roche (RHHVF) and SINR PHAR/PAR VTG FPD 0.01 (SPH). What other stocks do shareholders of Sanofi own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include Skechers USA (SKX), Encana (ECA), Sanofi (SNY), Tronox (TROX), Medifast (MED), Kontrol Energy (KNR), Baidu (BIDU), Bank of America (BAC), ImmunoGen (IMGN) and Intuitive Surgical (ISRG). Who are Sanofi's key executives? Sanofi's management team includes the folowing people: Mr. Olivier Brandicourt, CEO & Director (Age 63)Mr. Jean-Baptiste Chasseloup de Chatillon, Exec. VP & CFO (Age 54)Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. AccountingMr. Bruno Ménard, Chief Information officerMr. George Grofik, Head of Investor Relations What is Sanofi's stock price today? One share of SAN stock can currently be purchased for approximately €90.90. What is Sanofi's official website? The official website for Sanofi is http://en.sanofi.com/. How can I contact Sanofi? Sanofi's mailing address is 54 rue la Boetie, PARIS, 75008, France. The company can be reached via phone at +33-1-53774000. MarketBeat Community Rating for Sanofi (EPA SAN)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 564 (Vote Outperform)Underperform Votes: 657 (Vote Underperform)Total Votes: 1,221MarketBeat's community ratings are surveys of what our community members think about Sanofi and other stocks. Vote "Outperform" if you believe SAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SAN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/27/2020 by MarketBeat.com StaffFeatured Article: How does a dividend reinvestment plan work?
